The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Gelman, Benjamin B ^a   Chen, Tiansheng ^a   Lisinicchia, Joshua G ^a   Soukup, Vicki M ^a   Carmical, J Russ ^a   Starkey, Jonathan M ^a   Masliah, Eliezer ^b   Commins, Deborah L ^c   Brandt, Dianne ^d   Grant, Igor ^e   Singer, Elyse J ^f   Levine, Andrew J ^f   Miller, Jeremy ^g   Winkler, Jessica M ^h   Fox, Howard S ^h   Luxon, Bruce A ^a   Morgello, Susan ⁱ  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d EMMES CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CD163 ANTIGEN; CLATHRIN; COMPLEMENT; GLUTAMIC ACID; PROTEIN 14 3 3;

ADULT; ANTIGEN PRESENTATION; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENDOCYTOSIS; FEMALE; GENE; GENE EXPRESSION; GENE PROBE; GENETIC TRANSCRIPTION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNE RESPONSE; INTERFERON RESPONSE GENE; MALE; NATIONAL HEALTH ORGANIZATION; NATIONAL NEUROAIDS TISSUE CONSORTIUM; NEOCORTEX; NEOSTRIATUM; NERVE FIBER; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION; UPREGULATION; VIRUS LOAD; WHITE MATTER;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CELL SURFACE; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866860448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046178     Document Type: Article

References (95)

1. Budka H, (1991) Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163-175.
2. Glass JD, Fedor H, Wesselingh SL, McArthur JC, (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
3. Glass JD, Wesselingh SL, Selnes OA, McArthur JC, (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43: 2230-2237.
4. Wiley CA, Achim C, (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36: 673-676.
5. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, et al. (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 15: 360-370.
6. Masliah E, DeTeresa RM, Mallory ME, Hansen LA, (2000) Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 14: 69-74.
7. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K, (2002) Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 126: 182-190.
8. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
9. Heaton RK, Grant I, Butters N, White DA, Kirson D, et al. (1995) The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1: 231-251.
10. McArthur JC, (2004) HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
11. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
12. Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, et al. (2005) Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 170: 158-171.
13. Gelman BB, Spencer JA, Holzer CE 3rd, Soukup VM, (2006) Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 1: 410-420.
14. Masliah E, Roberts ES, Langford D, Everall I, Crews L, et al. (2004) Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157: 163-175.
15. Roberts ES, Masliah E, Fox HS, (2004) CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 63: 1255-1264.
16. Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, et al. (2003) Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am J Pathol 162: 2041-2057.
17. Burdo TH, Ellis RJ, Fox HS, (2008) Osteopontin is increased in HIV-associated dementia. J Infect Dis 198: 715-722.
18. Gelman BB, Soukup VM, Schuenke KW, Keherly MJ, Holzer C 3rd, et al (2004) Acquired neuronal channelopathies in HIV-associated dementia. J Neuroimmunol 157: 111-119.
19. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS, (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS One 3: e2906.
20. Gelman BB, Soukup VM, Holzer CE, 3rd, Fabian RH, Schuenke KW, et al (2005) Potential role for white matter lysosome expansion in HIV-associated dementia. J Acquir Immune Defic Syndr 39: 422-425.
21. Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, et al. (2001) The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27: 326-335.
22. Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, et al. (2011) Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol 17: 248-257.
23. Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, et al. (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16: 1019-1029.
24. Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, et al. (2007) Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 19: 283-292.
25. Schmidbauer M, Huemer M, Cristina S, Trabattoni GR, Budka H, (1992) Morphological spectrum, distribution and clinical correlation of white matter lesions in AIDS brains. Neuropathol Appl Neurobiol 18: 489-501.
26. Xing HQ, Moritoyo T, Mori K, Tadakuma K, Sugimoto C, et al. (2003) Simian immunodeficiency virus encephalitis in the white matter and degeneration of the cerebral cortex occur independently in simian immunodeficiency virus-infected monkey. J Neurovirol 9: 508-518.
27. Achim CL, Wang R, Miners DK, Wiley CA, (1994) Brain viral burden in HIV infection. J Neuropathol Exp Neurol 53: 284-294.
28. Buesa C, Maes T, Subirada F, Barrachina M, Ferrer I, (2004) DNA chip technology in brain banks: confronting a degrading world. J Neuropathol Exp Neurol 63: 1003-1014.
29. Ervin JF, Heinzen EL, Cronin KD, Goldstein D, Szymanski MH, et al. (2007) Postmortem delay has minimal effect on brain RNA integrity. J Neuropathol Exp Neurol 66: 1093-1099.
30. Lee J, Hever A, Willhite D, Zlotnik A, Hevezi P, (2005) Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J 19: 1356-1358.
31. Boehm U, Klamp T, Groot M, Howard JC, (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15: 749-795.
32. Brooimans RA, Hiemstra PS, van der Ark AA, Sim RB, van Es LA, et al. (1989) Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma. J Immunol 142: 2024-2030.
33. Furman C, Sieminski AL, Kwiatkowski AV, Rubinson DA, Vasile E, et al. (2007) Ena/VASP is required for endothelial barrier function in vivo. J Cell Biol 179: 761-775.
34. Jahroudi N, Lynch DC, (1994) Endothelial-cell-specific regulation of von Willebrand factor gene expression. Mol Cell Biol 14: 999-1008.
35. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, et al. (1984) Transferrin receptor on endothelium of brain capillaries. Nature 312: 162-163.
36. McCarthy MJ, Crowther M, Bell PR, Brindle NP, (1998) The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor. FEBS Lett 423: 334-338.
37. Ohno M, Cooke JP, Dzau VJ, Gibbons GH, (1995) Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest 95: 1363-1369.
38. Ripoche J, Mitchell JA, Erdei A, Madin C, Moffatt B, et al. (1988) Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J Exp Med 168: 1917-1922.
39. Tar K, Birukova AA, Csortos C, Bako E, Garcia JG, et al. (2004) Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation. J Cell Biochem 92: 534-546.
40. Vastag M, Skopal J, Kramer J, Kolev K, Voko Z, et al. (1998) Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4. Immunobiology 199: 5-13.
41. Oide T, Yoshida K, Kaneko K, Ohta M, Arima K, (2006) Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Neuropathol Appl Neurobiol 32: 170-176.
42. de Chaldee M, Gaillard MC, Bizat N, Buhler JM, Manzoni O, et al. (2003) Quantitative assessment of transcriptome differences between brain territories. Genome Res 13: 1646-1653.
43. Greengard P, (2001) The neurobiology of slow synaptic transmission. Science 294: 1024-1030.
44. Deutch AY, Colbran RJ, Winder DJ, (2007) Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat Disord 13Suppl 3: S251-258.
45. Surmeier DJ, Ding J, Day M, Wang Z, Shen W, (2007) D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 30: 228-235.
46. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, et al. (1983) Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309: 453-458.
47. Gelman BB, (2007) The neuropathology of HIV. Handb Clin Neurol 85: 301-317.
48. Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F, (2003) The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 62: 429-440.
49. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, et al. (1997) Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 42: 963-972.
50. Fox HS, (2008) Virus-host interaction in the simian immunodeficiency virus-infected brain. J Neurovirol 14: 286-291.
51. Roberts ES, Huitron-Resendiz S, Taffe MA, Marcondes MC, Flynn CT, et al. (2006) Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J Neurosci 26: 4577-4585.
52. Kaul M, Garden GA, Lipton SA, (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
53. Williams KC, Hickey WF, (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25: 537-562.
54. Potash MJ, Chao W, Bentsman G, Paris N, Saini M, et al. (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci U S A 102: 3760-3765.
55. Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, et al. (2004) Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J Neuroimmunol 157: 81-92.
56. Sas AR, Bimonte-Nelson HA, Tyor WR, (2007) Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain. AIDS 21: 2151-2159.
57. Zink MC, Brice AK, Kelly KM, Queen SE, Gama L, et al. (2010) Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis 202: 161-170.
58. Masliah E, Ge N, Achim CL, Wiley CA, (1995) Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 54: 350-357.
59. Tepper JM, Koos T, Wilson CJ, (2004) GABAergic microcircuits in the neostriatum. Trends Neurosci 27: 662-669.
60. Benes FM, Berretta S, (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1-27.
61. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, et al. (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165: 479-489.
62. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, et al. (2004) Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5: 793-807.
63. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, et al. (2009) Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 4: e6585.
64. Sibille E, Morris HM, Kota RS, Lewis DA, (2011) GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol 14: 721-734.
65. Ke Y, Streeter CC, Nassar LE, Sarid-Segal O, Hennen J, et al. (2004) Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 130: 283-293.
66. Baldeweg T, Gruzelier JH, (1997) Alpha EEG activity and subcortical pathology in HIV infection. Int J Psychophysiol 26: 431-442.
67. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA, (1992) Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51: 585-593.
68. An SF, Giometto B, Groves M, Miller RF, Beckett AA, et al. (1997) Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56: 1262-1268.
69. Gelman BB, Nguyen TP, (2010) Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. J Neuroimmune Pharmacol 5: 92-102.
70. Banks WA, (2006) The blood-brain barrier as a regulatory interface in the gut-brain axes. Physiol Behav 89: 472-476.
71. Hawkins BT, Davis TP, (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185.
72. de Larranaga GF, Bocassi AR, Puga LM, Alonso BS, Benetucci JA, (2003) Endothelial markers and HIV infection in the era of highly active antiretroviral treatment. Thromb Res 110: 93-98.
73. Kristoffersen US, Kofoed K, Kronborg G, Giger AK, Kjaer A, et al. (2009) Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. HIV Med 10: 79-87.
74. Melendez MM, McNurlan MA, Mynarcik DC, Khan S, Gelato MC, (2008) Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease. Clin Infect Dis 46: 775-780.
75. Ross AC, Armentrout R, O'Riordan MA, Storer N, Rizk N, et al. (2008) Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr 49: 499-506.
76. Abbott NJ, Ronnback L, Hansson E, (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53.
77. Banks WA, Ercal N, Price TO, (2006) The blood-brain barrier in neuroAIDS. Curr HIV Res 4: 259-266.
78. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, et al. (1993) Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 34: 339-350.
79. Toborek M, Lee YW, Flora G, Pu H, Andras IE, et al. (2005) Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 25: 181-199.
80. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, et al. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3: e2516.
81. Aird WC, (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777.
82. Wang Q, Du F, Qian ZM, Ge XH, Zhu L, et al. (2008) Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 149: 3920-3925.
83. Zhao B, Bowden RA, Stavchansky SA, Bowman PD, (2001) Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 281: C1587-1595.
84. Nath A, Anderson C, Jones M, Maragos W, Booze R, et al. (2000) Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14: 222-227.
85. Wang GJ, Chang L, Volkow ND, Telang F, Logan J, et al. (2004) Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 127: 2452-2458.
86. Ernst T, Chang L, Jovicich J, Ames N, Arnold S, (2002) Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59: 1343-1349.
87. Melrose RJ, Tinaz S, Castelo JM, Courtney MG, Stern CE, (2008) Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 188: 337-347.
88. Borjabad A, Morgello S, Chao W, Kim SY, Brooks AI, et al. (2011) Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders. PLoS Pathog 7: e1002213.
89. Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, et al. (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26: 759-778.
90. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, et al. (2006) The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 7: 3.
91. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41: 4531-4536.
92. Boulesteix AL, Strimmer K, (2007) Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinform 8: 32-44.
93. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, et al. (2003) Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19: 1945-1951.
94. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I, (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
95. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.